Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
16.8M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$17.8M
-
Value change
-
-$3.03M
-
Number of buys
-
14
-
Number of sells
-
-29
-
Price
-
$1.06
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2022
64 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2022.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.8M shares
of 96M outstanding shares and own 17.49% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2.54M shares), 5AM Venture Management, LLC (2.06M shares), SAMLYN CAPITAL, LLC (1.92M shares), CITADEL ADVISORS LLC (1.25M shares), Cormorant Asset Management, LP (1.15M shares), VANGUARD GROUP INC (1.05M shares), Ikarian Capital, LLC (944K shares), Redmile Group, LLC (696K shares), BAKER BROS. ADVISORS LP (662K shares), and Kynam Capital Management, LP (547K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.